Clinical Trials
50 trialsESME OC
UNICANCER
Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women
Women's Hospital School Of Medicine Zhejiang University
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies
National Institutes of Health Clinical Center (CC)
SCOUT-1
AstraZeneca
BIOC
KU Leuven
PRSTEC_multipr
University Hospital Hradec Kralove
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Tampere University Hospital
COLTEP
University Hospital, Brest
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
M.D. Anderson Cancer Center
Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
M.D. Anderson Cancer Center
DESCENT-1
A2 Biotherapeutics Inc.
V-COSMOS
Cukurova University
ANIHTA
Instituto do Cancer do Estado de São Paulo
CASCADE3002
UNC Lineberger Comprehensive Cancer Center
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
OvAR-Y
Washington University School of Medicine
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
M.D. Anderson Cancer Center
PRIORITY
Pontificia Universidad Catolica de Chile
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
Tongji Hospital
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
NYU Langone Health
RESO
Zhejiang Cancer Hospital
F-IOTA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CASCADE
University of Basel
MONITOR-UK
Royal Marsden NHS Foundation Trust
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
AstraZeneca
Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
University of Aarhus
Follow-up in Gynecological Cancer Survivors
European Organisation for Research and Treatment of Cancer - EORTC
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
UNC Lineberger Comprehensive Cancer Center
Bio-CHECC
University of Manchester
DUOLife
AstraZeneca
GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
University of Southern California
MIRA
University of British Columbia
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
LONGEVITI
University of Alberta
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
National Institutes of Health Clinical Center (CC)
GEORGIA
Ohio State University Comprehensive Cancer Center
LPSvsLPT
Azienda USL Reggio Emilia - IRCCS
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
M.D. Anderson Cancer Center
iCaRe2
University of Nebraska
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
University of Wisconsin, Madison
retroESGO ov1
European Society of Gynaecological Oncology
REFLECT
University Health Network, Toronto
Sub-type Specific Genomic Mutations in sBOTs
Universitair Ziekenhuis Brussel
PRO-GRO
UNC Lineberger Comprehensive Cancer Center
Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening
University of California, San Francisco